HMCC attracts investor Holland Capital for further growth
Amsterdam, 2 November 203 – Investment firm Holland Capital is investing in HMCC Medical Group (HMCC), a provider that offers remote support for primary care. The investment is led by Holland Capital, in partnership with Weijenberg Invest. With this investment, HMCC can further develop its services and technologies.
Remote Healthcare
The Dutch healthcare system is facing challenges due to an aging population and a shortage of healthcare professionals. This highlights the need for solutions like HMCC that optimize resources while improving the quality of care. HMCC is committed to improve the accessibility of general practitioner practices and clinics. By deploying a professional medical team, HMCC relieves the pressure on practices and medical staff, allowing them to focus on patient care. HMCC’s team consists of experienced medical assistants, triage personnel, and nurses who provide remote expert advice to patients. They carefully assess the urgency of medical inquiries and facilitate effective communication. The on-site assistant in the general practitioner’s office can then fully concentrate on providing physical care to patients.
Innovative Growth
With the investment, HMCC can further develop and expand its services and technologies to better meet the growing demand for remote healthcare.
“The approach of HMCC contributes to improving the accessibility of the general practitioner’s office for patients and reducing the workload at the practice. We are excited to invest in a company that plays a central role in efficiently facilitating remote healthcare,” says Jan-Frens van Giessel, partner at Holland Capital. Following the investment in the healthcare platform HealthConnected in 2020, this is Holland Capital’s second investment focused on efficiency and digitalization in primary care.
Patrick Eliasar, CEO of HMCC, says, “Thanks to the investment from Holland Capital, we can expand our services and further develop the technology to meet the growing needs of remote healthcare. The investment also allows us to move forward with a much clearer vision of the future of healthcare, where the role of remote patient care becomes not only essential for general practitioners, hospitals, and clinics but also for pharmacies, for example.”
About HMCC
HMCC is a leading medical contact center specializing in improving the accessibility of general practitioner practices. With a team of experienced professionals, HMCC provides solutions that contribute to quality healthcare and remote care. Dozens of general practitioner practices and clinics already use HMCC’s services.
About Holland Capital
For the past 40 years, Holland Capital has responsibly and successfully invested in over 180 promising companies. With a clear investment strategy, the firm is active in attractive growth markets, including Healthcare, Technology, and Agrifood. The experienced and engaged investment team understands what entrepreneurship entails. They aim for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs and has offices in Amsterdam and Düsseldorf.
Succesvolle financieringsronde voor innovatief beademingsapparaat van Ventinova
Eindhoven, 26 november 2015 – Ventinova Group B.V. heeft een succesvolle tweede financieringsronde afgerond met haar bestaande aandeelhouders Holland Venture en de Brabantse Ontwikkelings Maatschappij (BOM). Daarnaast is een nieuwe aandeelhouder toegetreden,...
Holland Venture realiseert uitstekend resultaat door verkoop Bureau PENG
Amsterdam 6 oktober 2015 - Vorig week heeft Holland Venture de overnamecontracten getekend waarmee zij haar aandelen in Bureau PENG heeft verkocht aan de huidige directeur Martijn van Kraaij en een Nederlandse family office. Bureau PENG biedt flexibele personele...
Substantiële EU subsidie voor revolutionaire levensreddende beademingsmethode
Eindhoven 24 september 2015 - Ventinova Medical B.V., een bedrijf dat innovatieve medische producten ontwikkelt en verkoopt op het gebied van anesthesiologie heeft samen met drie partners een EU subsidie ontvangen van EUR 1,9 miljoen. Als derde geselecteerd van de 269...
Holland Venture start technologie fonds
Amsterdam, 20 augustus 2015 - Holland Venture heeft een nieuw fonds opgezet voor jonge, snelgroeiende technologie bedrijven. Het Holland Venture Technologie Fonds richt zich op zes specifieke aandachtsgebieden: mobiel internet, software in de cloud,...
Holland Venture investeert enkele miljoenen in RDW Tandartsen
Amsterdam, 5 augustus 2015 - Participatiemaatschappij Holland Venture investeert enkele miljoenen in RDW Tandartsen, een tandartsengroep van zes praktijken. De praktijken van RDW Tandartsen bieden mondzorg met verschillende specialismen. De investering stelt de...
Nieuwe financieringsronde voor SigmaScreening van bestaande en nieuwe investeerders
Amsterdam, 19 juni 2015 – SigmaScreening B.V. heeft een succesvolle financieringsronde afgesloten met bestaande aandeelhouders waaronder Holland Venture en nieuwe investeerder De Friesland Zorgverzekeraar (DFZ). SigmaScreening, een spin off van het Academisch Medisch...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl